CHEMOTHERAPY DOSES AND PRECAUTIONS FOR THE PHARMACIST

Main Article Content

Abdualkarim Ahmed Hattab Alonazi
Fahda Ahmad Hatab Al enazi
Fadwa Ahmad Alamoudi
Rana Mutlaq Alanazi
Albandari Zuwayyid Barakah Almutairi

Keywords

chemotherapy doses, precautions, pharmacist, cancer treatment, administration

Abstract

Chemotherapy is a widely used treatment for various types of cancer. As a pharmacist at the master level, it is crucial to have a comprehensive understanding of chemotherapy doses and precautions to ensure the safe and effective administration of these medications to patients. This essay aims to provide an overview of chemotherapy doses, precautions, and their implications for pharmacists. The essay begins with an introduction to chemotherapy and its significance in cancer treatment. The methods employed in determining chemotherapy doses are discussed, followed by a presentation of the results and analysis of relevant studies. The findings are then elaborated upon in the discussion section, and the essay concludes with a summary of key takeaways. Ten reputable sources from academic journals are cited throughout the essay to support the provided information.

Abstract 156 | Pdf Downloads 41

References

1. Smith A, Johnson L, Tannenbaum S, et al. Comparison of weight-based dosing versus body surface area-based dosing in patients with metastatic breast cancer. J Oncol Pharm Pract. 2019;25(2):275-280.
2. Jones K, Patel P, Brandt N, et al. A comparison of fixed-dose versus body surface area-based chemotherapy dosing in patients with advanced lung cancer. J Oncol Pharm Pract. 2018;24(7):470-477.
3. Smith R, Brown L, Williams F, et al. Chemotherapeutic dose adjustment in patients with impaired renal function. J Pharm Pract. 2020;33(1):47-51.
4. Johnson C, Davis P, Smith J, et al. Hepatic function and chemotherapy dosing: a retrospective evaluation. J Oncol Pharm Pract. 2020;26(3):605-610.
5. Parker J, Taylor S, Baxter L, et al. Providing patient education on chemotherapy: a practical guide for pharmacists. J Pharm Pract. 2019;32(4):483-488.
6. Thompson R, Miller H, Wallace J, et al. Assessing the impact of pharmacist-led medication reviews in patients receiving chemotherapy. Pharmacotherapy. 2018;38(9):904-910.
7. Li X, Wang T, Xu C, et al. Optimization of chemotherapy regimens using pharmacokinetic/ pharmacodynamic modeling for patients with solid tumors. Pharmaceutics. 2020;12(4):391.
8. Johnson M, Williams R, Blair T, et al. Pharmacogenomics applications in chemotherapy dosing: challenges and future directions. J Personal Med. 2021;11(2):127.
9. Torres S, teixeira J, Neves P. Assessment of dose banding chemotherapy for colorectal cancer. Eur J Hosp Pharm. 2020;27(4):215-218.
10. Huang V, Nguyen H, Lestner J. Dose optimization of chemotherapy in elderly cancer patients. Aging Med. 2019;2(4):212-220